222 related articles for article (PubMed ID: 350460)
1. Differing surface marker characteristics in plasma cell dyscrasias with particular reference to IgM myeloma.
Burns GF; Cawley JC; Barker CR; Worman CP; Raper CG; Hayhoe FG
Clin Exp Immunol; 1978 Mar; 31(3):414-8. PubMed ID: 350460
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
Gallart T; Bladé J; MartÃnez-Quesada J; Sierra J; Rozman C; Vives J
Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
[TBL] [Abstract][Full Text] [Related]
3. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
[TBL] [Abstract][Full Text] [Related]
4. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
5. A study of immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells.
Ferrarini M; Viale G; Risso A; Pernis B
Eur J Immunol; 1976 Aug; 6(8):562-5. PubMed ID: 824142
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukaemia with subsequent development of multiple myeloma. Evidence of two B-lymphocyte clones and of myeloma-induced suppression of secretion of an M-component and of normal immunoglobulins.
Pedersen-Bjergaard J; Petersen HD; Thomsen M; Wiik A; Wolff-Jensen J
Scand J Haematol; 1978 Sep; 21(3):256-64. PubMed ID: 309624
[TBL] [Abstract][Full Text] [Related]
7. Most B cells that have switched surface immunoglobulin isotypes generate clones of cells that do not secrete IgM.
Gearhart PJ; Cebra JJ
J Immunol; 1981 Sep; 127(3):1030-4. PubMed ID: 6790608
[TBL] [Abstract][Full Text] [Related]
8. Human peripheral blood B cell subpopulations: surface IgD+ cells respond to pokeweed mitogen with plasma cell differentiation.
Mudde GC; van Dam D; De Gast GC
Clin Exp Immunol; 1986 Apr; 64(1):150-7. PubMed ID: 3488148
[TBL] [Abstract][Full Text] [Related]
9. Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma.
Levy Y; Schmitt C; Tsapis A; Brouet JC; Fermand JP
Clin Exp Immunol; 1991 Jun; 84(3):435-9. PubMed ID: 2044222
[TBL] [Abstract][Full Text] [Related]
10. Cell-bound immunoglobulin on peripheral blood mononuclear cells of patients with myeloma.
King MA; Wells JV
Clin Exp Immunol; 1981 Sep; 45(3):552-6. PubMed ID: 6175455
[TBL] [Abstract][Full Text] [Related]
11. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
[TBL] [Abstract][Full Text] [Related]
12. 'Mu' heavy chain type 'non-excretory' myeloma.
Guglielmo P; Granata P; Di Raimondo F; Lombardo T; Giustolisi R; Cacciola E
Scand J Haematol; 1982 Jul; 29(1):36-40. PubMed ID: 6812210
[TBL] [Abstract][Full Text] [Related]
13. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
Hibi T; Chan MA; Petsche D; Dosch HM
J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613
[TBL] [Abstract][Full Text] [Related]
14. Expression of an unidentified immunoglobulin isotype on rabbit Ig-bearing lymphocytes.
Eskinazi DP; Bessinger BA; McNicholas JM; Leary AL; Knight KL
J Immunol; 1979 Feb; 122(2):469-74. PubMed ID: 105045
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of bone marrow and blood B cells in infantile and acquired agammaglobulinemia. Possible role of circulating anti-IgM in pathogenesis.
Abdou NI; Casella SR; Abdou NL; Abrahamsohn IA
J Clin Invest; 1973 Sep; 52(9):2218-24. PubMed ID: 4580388
[TBL] [Abstract][Full Text] [Related]
16. [Immunological and electron microscope characteristics of peripheral blood lymphocytes in myeloma disease].
Abramenko IB; Iurchenko OV; Skliarenko LM; Nadgornaia VA; Vetrova EP
Eksp Onkol; 1987; 9(1):46-9, 52. PubMed ID: 3816658
[TBL] [Abstract][Full Text] [Related]
17. Isolation of various canine leucocytes and their characterization by surface marker analysis.
Ho CK; Babiuk LA
Immunology; 1978 Nov; 35(5):733-40. PubMed ID: 309854
[TBL] [Abstract][Full Text] [Related]
18. Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels.
Pilarski LM; Ruether BA; Mant MJ
J Clin Invest; 1985 Jun; 75(6):2024-9. PubMed ID: 2989339
[TBL] [Abstract][Full Text] [Related]
19. The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma.
Waldmann TA; Broder S; Krakauer R; MacDermott RP; Durm M; Goldman C; Meade B
Fed Proc; 1976 Jul; 35(9):2067-72. PubMed ID: 1084293
[TBL] [Abstract][Full Text] [Related]
20. Characterization of antiserum against myeloma cells.
Cawley LP; Goodwin WL; Minard BJ
Cancer Res; 1973 Jan; 33(1):17-22. PubMed ID: 4629871
[No Abstract] [Full Text] [Related]
[Next] [New Search]